WallStreetZenWallStreetZen

NASDAQ: TNYA
Tenaya Therapeutics Inc Stock

$3.07-0.17 (-5.25%)
Updated Feb 3, 2023
TNYA Price
$3.07
Fair Value Price
N/A
Market Cap
$127.02M
52 Week Low
$1.64
52 Week High
$16.17
P/E
-2.01x
P/B
0.65x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$116.30M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.15
Operating Cash Flow
-$98M
Beta
1.73
Next Earnings
Mar 22, 2023
Ex-Dividend
N/A
Next Dividend
N/A

TNYA Overview

Tenaya Therapeutics Incorporated is a biotechnology company that develops heart diseases therapies in the U.S. It uses cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic Hypertrophic Cardiomyopathy, and TN-301, a small molecule inhibitor of Histone Deacetylase 6 (HDAC6i) for use in heart gFailure with preserved ejection fraction (HFpEF), as well as genetic Dilated Cardiomyopathy (gDCM). The company was incorporated in 2016 and is headquartered in San Francisco, CA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TNYA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TNYA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TNYA is good value based on its book value relative to its share price (0.65x), compared to the US Biotechnology industry average (5.11x)
P/B vs Industry Valuation
TNYA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TNYA due diligence checks available for Premium users.

Be the first to know about important TNYA news, forecast changes, insider trades & much more!

TNYA News

Valuation

TNYA fair value

Fair Value of TNYA stock based on Discounted Cash Flow (DCF)
Price
$3.07
Fair Value
$2.92
Overvalued by
4.99%
TNYA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TNYA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.01x
Industry
10.7x
Market
15.09x

TNYA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.65x
Industry
5.11x
TNYA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TNYA's financial health

Profit margin

Revenue
$0.0
Net Income
-$30.7M
Profit Margin
0%
TNYA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$226.3M
Liabilities
$30.0M
Debt to equity
0.15
TNYA's short-term assets ($157.07M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TNYA's short-term assets ($157.07M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TNYA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$27.6M
Investing
$31.0M
Financing
$6.0k
TNYA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TNYA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TNYA$127.02M-5.25%-2.01x0.65x
GMDA$127.19M+2.40%-1.17x9.38x
CUE$126.68M+3.47%-2.61x2.50x
XBIT$126.32M-2.12%-3.49x0.52x
RVLP$124.93M-1.56%-2.03x1.82x

Tenaya Therapeutics Stock FAQ

What is Tenaya Therapeutics's quote symbol?

NASDAQ: TNYA) Tenaya Therapeutics trades on the NASDAQ under the ticker symbol TNYA. Tenaya Therapeutics stock quotes can also be displayed as NASDAQ: TNYA.

If you're new to stock investing, here's how to buy Tenaya Therapeutics stock.

What is the 52 week high and low for Tenaya Therapeutics (NASDAQ: TNYA)?

(NASDAQ: TNYA) Tenaya Therapeutics's 52-week high was $16.17, and its 52-week low was $1.64. It is currently -81.01% from its 52-week high and 87.2% from its 52-week low.

How much is Tenaya Therapeutics stock worth today?

(NASDAQ: TNYA) Tenaya Therapeutics currently has 41,374,508 outstanding shares. With Tenaya Therapeutics stock trading at $3.07 per share, the total value of Tenaya Therapeutics stock (market capitalization) is $127.02M.

Tenaya Therapeutics stock was originally listed at a price of $15.35 in Jul 30, 2021. If you had invested in Tenaya Therapeutics stock at $15.35, your return over the last 1 years would have been -80%, for an annualized return of -80% (not including any dividends or dividend reinvestments).

How much is Tenaya Therapeutics's stock price per share?

(NASDAQ: TNYA) Tenaya Therapeutics stock price per share is $3.07 today (as of Feb 3, 2023).

What is Tenaya Therapeutics's Market Cap?

(NASDAQ: TNYA) Tenaya Therapeutics's market cap is $127.02M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Tenaya Therapeutics's market cap is calculated by multiplying TNYA's current stock price of $3.07 by TNYA's total outstanding shares of 41,374,508.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.